Ledger.Open graph →
SEC Form D · filed October 14, 2025

Affinia Therapeutics Inc

Offering
$45.0M
Sold
$13.3M
Exemption
Rule 506(b)
Industry
Other
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Robert Weisskoff · WALTHAM, MADirectorSean Nolan · WALTHAM, MADirectorDavid Grayzel · WALTHAM, MADirectorEdward Mathers · WALTHAM, MADirectorLuc Vandenberghe · WALTHAM, MADirectorRick Modi · WALTHAM, MAExec · DirectorKaryn Smith · Bellevue, WADirectorPenny Pritzker · Bellevue, WADirectorJohn Connors · Bellevue, WADirectorMonish Darda · Bellevue, WAExec · DirectorKabir Narang · Bellevue, WADirectorSamir Bodas · Bellevue, WADirectorCarole Faig · WALTHAM, MADirectorRami Daoud · WALTHAM, MAExecDiana Brainard · WALTHAM, MADirectorElliott Sigal · Princeton, NJDirectorDaniel Galles · Jacksonville, FLDirectorKirk Moquin · Jacksonville, FLDirectorAlbert Prast · Jacksonville, FLExec · DirectorDan Wildermuth · Jacksonville, FLDirectorAng S. Zhao · Richmond, British Columbia, CanadaDirectorDaniel L. Titcomb · ST. PAUL, MNDirectorCarole Faig · WALTHAM, MADirectorRami Daoud · WALTHAM, MAExecDiana Brainard · WALTHAM, MADirectorElliott Sigal · Princeton, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗